Immix Biopharma, Inc. (IMMX) — Analyst estimates
Consensus analyst estimates for Immix Biopharma, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 0 | -0.19 | 2 |
| 2027 | 52.20M | -0.21 | 2 |
| 2028 | 178.63M | -0.38 | 2 |
| 2029 | 313.37M | 0.28 | 1 |
| 2030 | 481.05M | 1.85 | 1 |
Consensus analyst estimates by fiscal year.